ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD15 Antibody [MMA] (A86829)

Mouse monoclonal [MMA] antibody to CD15 for Flow Cytometry, IHC-P, IHC-Fr and ICC.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 5-8 business days.
Name
Anti-CD15 Antibody [MMA]
Description
Mouse monoclonal [MMA] antibody to CD15.
Specificity
This antibody reacts with an extracellular epitope of CD15, a cell membrane 3-fucosyl-N-acetyllactosamine (3-FAL) strongly expressed on granulocytes, monocytes, macrophages, and mast cells. It is also present on Langerhans cells and some myeloid precursors cells. This antibody is a superior reagent for identifying Hodgkin´s lymphoma.
Applications
Flow Cytometry, IHC-P, IHC-Fr, ICC
Dilutions
Flow Cytometry: 1-4 µg/ml.
Reactivity
Human
Immunogen
U937 histiocytic lymphoma cells.
Host
Mouse
Clonality
Monoclonal
Clone ID
MMA
Isotype
IgM
Light Chains
kappa
Conjugate

Unconjugated

Purification
Purified by differential precipitation and solid-phase chromatography.
Concentration
1 mg/ml
Product Form
Liquid
Formulation
Supplied in Tris Buffered Saline, pH 8, with 15 mM Sodium Azide.
Storage
Shipped at 4°C. Store at 2-8°C. Do not freeze!
Synonyms
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase, Alpha-(1,3)-fucosyltransferase 4, EC:2.4.1.152, ELAM-1 ligand fucosyltransferase, ELFT, FCT3A, Fuc-TIV, Fucosyltransferase 4, Fucosyltransferase IV, FucT-IV, FUT4, Galactoside 3-L-fucosyltransferase
Isotype Controls
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-CD15 Antibody [MMA] (A86829)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-CD15 Antibody [MMA] (A86829)

Proteins predicted to interact with CD15

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
98.6% Relevancy Score
97.9% Relevancy Score
93.4% Relevancy Score
92.7% Relevancy Score
92.7% Relevancy Score
92.5% Relevancy Score
92.5% Relevancy Score
92% Relevancy Score